DUBAI, 24th January, 2017 (WAM) — Dubai Creative Clusters Authority, DCCA, a government regulatory body mandated to foster the economic development of Dubai’s creative clusters and related knowledge industries, has signed a partnership agreement with the Ministry of Health and Prevention to support the healthcare sector and advance the pharmaceuticals industry.
It will also strengthen mutual cooperation in terms of developing licensing procedures and registering plants located in areas under DCCA’s jurisdiction to allow them to operate more efficiently.
The agreement was signed by Dr. Amin Hussein Al Amiri, Assistant Under-Secretary for Public Policy and Licensing of the Ministry of Health and Prevention, and Ahmad bin Bayat, Director-General of DCCA. It aims to develop mechanisms of collaboration and coordination towards advancing the pharmaceuticals industry and products as well as medical equipment in Dubai and the UAE.
In addition, the agreement stipulates that both parties execute UAE legislation pertaining to registering plants of pharmaceutical products and medical equipment, as well as to cooperate on overcoming challenges facing plants and investors.
Dr. Al Amiri said, “We are committed to our leadership’s directives that seek to elevate the healthcare sector and achieve the UAE Vision 2021 in terms of making the country one of the best globally in the quality of healthcare services. As part of our efforts to cooperate with many vital partners, our new partnership with DCCA will further boost the progress of the UAE healthcare sector.”
He pointed out that the UAE has become an attractive destination for global pharmaceuticals and medical equipment companies, with the number of plants now at 16, in addition to 18 more still awaiting initial approval, raising the total number of pharmaceuticals and medical equipment plants to 34 by 2020. Over 1,000 new and existing pharmaceutical products are made in the UAE.
Bin Bayat said, “Signing this agreement with the ministry is a very important addition to DCCA’s efforts to develop the pharmaceuticals industry. We are exerting all necessary efforts to help develop this sector by providing infrastructure and ensuring a suitable environment that attracts investments and experts to innovate and create, leading eventually to building our capacities in terms of pharmaceuticals production, research and development in Dubai and the UAE at large.”
DCCA will work on enhancing the pharmaceuticals industry, a vital sector with a market size exceeding AED11 billion in the UAE, by providing a stimulating environment for industry professionals and helping them grow their businesses. The authority will offer pharmaceutical companies operating in Dubai Science Park, DSP, a flexible regulatory framework that ensures ease of business and meets their demands through an integrated ecosystem that supports scientific research and innovation. Thanks to the support provided to businesses and entrepreneurs, DSP has become a headquarters for over 300 companies working in biosciences, energy and environment, including some of the top global names in the industry.
Marwan Abdulaziz Janahi, Executive Director of Dubai Science Park, said, “The initiative supports DSP’s strategy for attracting pioneering companies in the sector. DSP also aims to serve specialised companies, including startups, SMEs and large multinational corporations as part of its bid to become the preferred choice for businesses operating in the science sector.”
With the fast growth of the pharmaceuticals industry in the UAE, the partnership will provide further support to an already distinct legislative environment in the emirate and the country.